High-carb shakes can affect heart function: study

Image
Press Trust of India Washington
Last Updated : Mar 30 2016 | 7:32 PM IST
Drinking a high carbohydrate shake may have an acute and detrimental effect on heart function, researchers including one of Indian-origin have warned.
Scientists from the Vanderbilt University and University of Alabama at Birmingham (UAB) in the US studied 33 individuals who were given an acute carbohydrate load in the form of a 264-kilo-calorie shake.
They studied the subjects' blood levels for six hours looking for a number of things, chief among them whether this acute metabolic challenge could alter the heart's production of atrial natriuretic peptide (ANP).
ANP is a hormone that helps the body get rid of excess salt and reduces blood pressure.
If a high dietary carbohydrate load suppresses circulating ANP concentrations, this would be a disadvantage to obese individuals who have lower ANP levels to begin with, researchers said.
Before the participants began the study, they were normalised on a standard diet for a couple of days to remove any background dietary variability.
Researchers observed that drinking the high-carb shake led to a 25 per cent reduction in ANP in participants over the course of several hours.
"The carbohydrate load had a significant and notable effect on circulating ANP levels. Experimental studies suggest that it is not good to make less ANP," said Thomas Wang from Vanderbilt University.
Researchers also looked at the mechanism for the decrease in ANP levels. They were able to reproduce the findings in mice, and found that the principal driver for the acute reduction in ANP appeared to be the increase in glucose.
"When you take in a high-carb shake a lot of things happen, including increases in glucose and insulin. However, the increase in glucose appears to be the main thing driving the drop in ANP levels," said Wang.
Pankaj Arora from UAB helped to work out the novel chemical pathways that mediated the effect of glucose on heart cells.
This novel mechanism involved a molecule known as miR-425, which the research group has previously described as an inhibitor of ANP production. The glucose causes the cells to make more miR-425, and that, in turn, causes a reduction in ANP, researchers said.
The findings were published in the Journal of the American College of Cardiology (JACC).
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 30 2016 | 7:32 PM IST

Next Story